Agomelatine Prevents Relapse in Patients With Major Depressive Disorder Without Evidence of a Discontinuation Syndrome: A 24-Week Randomized, Double-Blind, Placebo-Controlled Trial
Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.4088/jcp.08m04548
Authors: Guy M. Goodwin, Robin Emsley, Sandra Rembry, Frédéric Rouillon, the Agomelatine Study Group
Institutions: Warneford Hospital, University of Oxford
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2059735897
